PLK1 and prostate neoplasm: Given the fact that the frequency of Ras gene mutations in prostate tumors is low (Carter et al., 1990), PLK1-induced activation of CRAF provides mechanistic insights into the aberrant activation of CRAF-MEK1/2-ERK1/2 signaling frequently detected in PCa.